Search results

Host institution [PL]: Instytut Hematologii i Transfuzjologii

Change search criteria ↓

20 projects found matching your search criteria:

1. AI-based model for fast and label-free identification of BAALC overexpression in acute myeloid leukemia cells

Principal investigator: Paulina Małgorzata Laskowska

Instytut Hematologii i Transfuzjologii

Call: PRELUDIUM 23, Panel: NZ1
2. Actin cytoskeleton disorders as a pro-survival signaling activator and a therapeutic biomarker in Diffuse Large B-cell L…

Principal investigator: dr Patryk Górniak

Instytut Hematologii i Transfuzjologii

Call: SONATA BIS 13, Panel: NZ5
3. Molecular mechanisms of DNA damage triggered by PIM kinases inhibition and its consequences for activation of innate imm…

Principal investigator: prof. Przemysław Juszczyński

Instytut Hematologii i Transfuzjologii

Call: OPUS 25, Panel: NZ5
4. Targeting of metabolic and transcriptomic cross-talk between leukemic cells and macrophages as a therapeutic strategy in…

Principal investigator: dr Monika Chomczyk

Instytut Hematologii i Transfuzjologii

Call: OPUS 22, Panel: NZ5
5. Mechanisms and consequences of CD19 loss in B-acute lymphoblastic leukaemia patients relapsing after CD19-CAR-T cell the…

Principal investigator: prof. Przemysław Juszczyński

Instytut Hematologii i Transfuzjologii

Call: PRELUDIUM BIS 3, Panel: NZ5
6. Role of RelA(p65) and cRel phosphorylations and their kinases in the biology of Diffuse-large B-cell lymphoma and Hodgki…

Principal investigator: dr Maciej Stefan Szydłowski

Instytut Hematologii i Transfuzjologii

Call: OPUS 22, Panel: NZ5
7. Expression, regulation and function of super-enhancer non-coding RNAs in Diffuse Large B-Cell Lymphoma (DLBCL)

Principal investigator: dr Sonia Maria Dębek

Instytut Hematologii i Transfuzjologii

Call: PRELUDIUM 20, Panel: NZ5
8. The proangiogenic functions of PIM kinases in plasma cell myeloma

Principal investigator: Filip Aleksander Garbicz

Instytut Hematologii i Transfuzjologii

Call: ETIUDA 8, Panel: NZ5
9. Dynamina-2 jako potencjalny cel terapeutyczny w chłoniaku rozlanym z dużych komórek B

Principal investigator: dr Patryk Górniak

Instytut Hematologii i Transfuzjologii

Call: SONATA 15, Panel: NZ5
10. Gankyrin protein as a new potential therapeutic target in multiple myeloma

Principal investigator: dr hab. Irena Misiewicz-Krzemińska

Instytut Hematologii i Transfuzjologii

Call: OPUS 18, Panel: NZ5
11. The role of PIM kinases in the vascular niche of multiple myeloma

Principal investigator: Filip Aleksander Garbicz

Instytut Hematologii i Transfuzjologii

Call: PRELUDIUM 16, Panel: NZ5
12. Role of histone H3 serine 10 (H3S10) kinases in deregulation of transcription in diffuse large B-cell lymphoma

Principal investigator: prof. Przemysław Juszczyński

Instytut Hematologii i Transfuzjologii

Call: OPUS 15, Panel: NZ5
13. Role of PIM kinases in the biology of classical Hodgkin lymphoma tumor-associated macrophages

Principal investigator: dr Maciej Stefan Szydłowski

Instytut Hematologii i Transfuzjologii

Call: SONATA 13, Panel: NZ5
14. Genetic features of Reed-Sternberg cells and their interplay with macrophages in classical Hodgkin lymphoma: identificat…

Principal investigator: prof. Przemysław Juszczyński

Instytut Hematologii i Transfuzjologii

Call: HARMONIA 8, Panel: NZ5
15. Significance of PIM-1 kinase mutations in progression of chronic lymphocytic leukemia

Principal investigator: dr Bartosz Puła

Instytut Hematologii i Transfuzjologii

Call: SONATA 11, Panel: NZ5
16. Molecular mechanisms linking BRAF mutations and the expression of immunoregulatory molecules, galectin-1 and PD-L1 in me…

Principal investigator: Maja Magdalena Wasylecka-Juszczyńska

Instytut Hematologii i Transfuzjologii

Call: PRELUDIUM 8, Panel: NZ5
17. Integrity of E3 ubiquitin ligase complex as a biomarker of response to treatment with immunomodulatory drugs in patients…

Principal investigator: dr hab. Ewa Lech-Marańda

Instytut Hematologii i Transfuzjologii

Call: OPUS 7, Panel: NZ5
18. Mechanism of SYK-mediated suppression of differentiation and apoptosis in acute myeloid leukemia (AML)

Principal investigator: dr Anna Polak

Instytut Hematologii i Transfuzjologii

Call: PRELUDIUM 6, Panel: NZ5
19. PIM kinases as rational therapeutic targets in lymphoid malignancies.

Principal investigator: dr hab. Przemysław Juszczyński

Instytut Hematologii i Transfuzjologii

Call: OPUS 2, Panel: NZ4
20. Identification and targeting molecular drug resistance mechanisms in adult B-cell acute lymphoblastic leukemia

Principal investigator: dr hab. Przemysław Juszczyński

Instytut Hematologii i Transfuzjologii

Call: OPUS 1, Panel: NZ4

Projects search

Search results